semaglutide monograph Wegovy (semaglutide) Dosage & Prescription

These results suggest that IF ameliorates glucocorticoid-induced bone loss primarily by suppressing osteoclastogenesis and PTH secretion and promoting osteoblastic activity

According to the FDA label, semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or prior serious hypersensitivity to semaglutide

Reduces appetite, helping maintain a calorie deficit

This is not a recommended practice unless you fully understand the sterile technique and storage requirements involved, and resources like peptide storage guidelines become essential reading